The Pirbright Institute grants new license for foot-and-mouth disease vaccine
The Pirbright Institute and its research partners have granted MSD Animal Health an exclusive commercial licence for a new, effective and affordable vaccine to protect livestock against several serotypes of foot-and-mouth disease virus (FMDV).
2 September 2019
5 minute read
By: "Many successful findings at the bench fail to progress to commerce as their manufacture is problematic. It is particularly gratifying therefore that MSD Animal Health have engaged fully with our recombinant vaccine for foot-and-mouth disease. I look forward to seeing their industrial know-how catapult the product into the commercial arena to provide a cost effective and safe vaccine to the benefit of industrial and subsistence farmers alike."
-Professor Ian Jones, Professor of Virology at the University of Reading-
